Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. S-3MEF Other S-3MEF
  2. 8-K Event Other events
  3. 424B5 Offering Prospectus
  4. 8-K Event Regulation FD disclosure · Other events
  5. 8-K Event Regulation FD disclosure · Other events
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. ARS Other Annual Report to Security Holders
  9. DEFA14A Proxy Proxy Materials
  10. DEF 14A Proxy Proxy Statement
  11. 8-K Event Auditor change
  12. 8-K Event Regulation FD disclosure · Other events
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 4 Planned sale CEO sold 5,394 shares at $2.02 ($10,894)
  20. 4 Planned sale SVP, Chief Financial Officer sold 474 shares at $2.02 ($957)

Page 3 of 37 · 731 filings